Cargando…
Natural Compound α-PGG and Its Synthetic Derivative 6Cl-TGQ Alter Insulin Secretion: Evidence for Diminishing Glucose Uptake as a Mechanism
PURPOSE: Previously we showed that natural compound α-penta-galloyl-glucose (α-PGG) and its synthetic derivative 6-chloro-6-deoxy-1,2,3,4-tetra-O-galloyl-α-D-glucopyranose (6Cl-TGQ) act to improve insulin signaling in adipocytes by increasing glucose transport. In this study, we investigated the mec...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917315/ https://www.ncbi.nlm.nih.gov/pubmed/33658814 http://dx.doi.org/10.2147/DMSO.S284295 |
_version_ | 1783657673008349184 |
---|---|
author | Chen, Xiaozhuo Daniels, Nigel A Cottrill, David Cao, Yanyang Wang, Xuan Li, Yunsheng Shriwas, Pratik Qian, Yanrong Archer, Michael W Whitticar, Nicholas B Jahan, Ishrat Nunemaker, Craig S Guo, Aili |
author_facet | Chen, Xiaozhuo Daniels, Nigel A Cottrill, David Cao, Yanyang Wang, Xuan Li, Yunsheng Shriwas, Pratik Qian, Yanrong Archer, Michael W Whitticar, Nicholas B Jahan, Ishrat Nunemaker, Craig S Guo, Aili |
author_sort | Chen, Xiaozhuo |
collection | PubMed |
description | PURPOSE: Previously we showed that natural compound α-penta-galloyl-glucose (α-PGG) and its synthetic derivative 6-chloro-6-deoxy-1,2,3,4-tetra-O-galloyl-α-D-glucopyranose (6Cl-TGQ) act to improve insulin signaling in adipocytes by increasing glucose transport. In this study, we investigated the mechanism of actions of α-PGG and 6Cl-TGQ on insulin secretion. METHODS: Mouse islets and/or INS-1832/13 beta-cells were used to test the effects of our compounds on glucose-stimulated insulin secretion (GSIS), intracellular calcium [Ca(2+)](i) using fura-2AM, glucose transport activity via a radioactive glucose uptake assay, intracellular ATP/ADP, and extracellular acidification (ECAR) and mitochondrial oxygen consumption rates (OCAR) using Seahorse metabolic analysis. RESULTS: Both compounds reduced GSIS in beta-cells without negatively affecting cell viability. The compounds primarily diminished glucose uptake into islets and beta-cells. Despite insulin-like effects in the peripheral tissues, these compounds do not act through the insulin receptor in islets. Further interrogation of the stimulus-secretion pathway showed that all the key metabolic factors involved in GSIS including ECAR, OCAR, ATP/ADP ratios, and [Ca(2+)](i) of INS-1832/13 cells were diminished after the compound treatment. CONCLUSION: The compounds suppress glucose uptake of the beta-cells, which consequently slows down the rates of glycolysis and ATP synthesis, leading to decrease in [Ca(2+)](i) and GSIS. The difference between adipocytes and beta-cells in effects on glucose uptake is of great interest. Further structural and functional modifications could produce new compounds with optimized therapeutic potentials for different target cells. The higher potency of synthetic 6Cl-TGQ in enhancing insulin signaling in adipocytes but lower potency in reducing glucose uptake in beta-cells compared to α-PGG suggests the feasibility of such an approach. |
format | Online Article Text |
id | pubmed-7917315 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-79173152021-03-02 Natural Compound α-PGG and Its Synthetic Derivative 6Cl-TGQ Alter Insulin Secretion: Evidence for Diminishing Glucose Uptake as a Mechanism Chen, Xiaozhuo Daniels, Nigel A Cottrill, David Cao, Yanyang Wang, Xuan Li, Yunsheng Shriwas, Pratik Qian, Yanrong Archer, Michael W Whitticar, Nicholas B Jahan, Ishrat Nunemaker, Craig S Guo, Aili Diabetes Metab Syndr Obes Original Research PURPOSE: Previously we showed that natural compound α-penta-galloyl-glucose (α-PGG) and its synthetic derivative 6-chloro-6-deoxy-1,2,3,4-tetra-O-galloyl-α-D-glucopyranose (6Cl-TGQ) act to improve insulin signaling in adipocytes by increasing glucose transport. In this study, we investigated the mechanism of actions of α-PGG and 6Cl-TGQ on insulin secretion. METHODS: Mouse islets and/or INS-1832/13 beta-cells were used to test the effects of our compounds on glucose-stimulated insulin secretion (GSIS), intracellular calcium [Ca(2+)](i) using fura-2AM, glucose transport activity via a radioactive glucose uptake assay, intracellular ATP/ADP, and extracellular acidification (ECAR) and mitochondrial oxygen consumption rates (OCAR) using Seahorse metabolic analysis. RESULTS: Both compounds reduced GSIS in beta-cells without negatively affecting cell viability. The compounds primarily diminished glucose uptake into islets and beta-cells. Despite insulin-like effects in the peripheral tissues, these compounds do not act through the insulin receptor in islets. Further interrogation of the stimulus-secretion pathway showed that all the key metabolic factors involved in GSIS including ECAR, OCAR, ATP/ADP ratios, and [Ca(2+)](i) of INS-1832/13 cells were diminished after the compound treatment. CONCLUSION: The compounds suppress glucose uptake of the beta-cells, which consequently slows down the rates of glycolysis and ATP synthesis, leading to decrease in [Ca(2+)](i) and GSIS. The difference between adipocytes and beta-cells in effects on glucose uptake is of great interest. Further structural and functional modifications could produce new compounds with optimized therapeutic potentials for different target cells. The higher potency of synthetic 6Cl-TGQ in enhancing insulin signaling in adipocytes but lower potency in reducing glucose uptake in beta-cells compared to α-PGG suggests the feasibility of such an approach. Dove 2021-02-24 /pmc/articles/PMC7917315/ /pubmed/33658814 http://dx.doi.org/10.2147/DMSO.S284295 Text en © 2021 Chen et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Chen, Xiaozhuo Daniels, Nigel A Cottrill, David Cao, Yanyang Wang, Xuan Li, Yunsheng Shriwas, Pratik Qian, Yanrong Archer, Michael W Whitticar, Nicholas B Jahan, Ishrat Nunemaker, Craig S Guo, Aili Natural Compound α-PGG and Its Synthetic Derivative 6Cl-TGQ Alter Insulin Secretion: Evidence for Diminishing Glucose Uptake as a Mechanism |
title | Natural Compound α-PGG and Its Synthetic Derivative 6Cl-TGQ Alter Insulin Secretion: Evidence for Diminishing Glucose Uptake as a Mechanism |
title_full | Natural Compound α-PGG and Its Synthetic Derivative 6Cl-TGQ Alter Insulin Secretion: Evidence for Diminishing Glucose Uptake as a Mechanism |
title_fullStr | Natural Compound α-PGG and Its Synthetic Derivative 6Cl-TGQ Alter Insulin Secretion: Evidence for Diminishing Glucose Uptake as a Mechanism |
title_full_unstemmed | Natural Compound α-PGG and Its Synthetic Derivative 6Cl-TGQ Alter Insulin Secretion: Evidence for Diminishing Glucose Uptake as a Mechanism |
title_short | Natural Compound α-PGG and Its Synthetic Derivative 6Cl-TGQ Alter Insulin Secretion: Evidence for Diminishing Glucose Uptake as a Mechanism |
title_sort | natural compound α-pgg and its synthetic derivative 6cl-tgq alter insulin secretion: evidence for diminishing glucose uptake as a mechanism |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917315/ https://www.ncbi.nlm.nih.gov/pubmed/33658814 http://dx.doi.org/10.2147/DMSO.S284295 |
work_keys_str_mv | AT chenxiaozhuo naturalcompoundapgganditssyntheticderivative6cltgqalterinsulinsecretionevidencefordiminishingglucoseuptakeasamechanism AT danielsnigela naturalcompoundapgganditssyntheticderivative6cltgqalterinsulinsecretionevidencefordiminishingglucoseuptakeasamechanism AT cottrilldavid naturalcompoundapgganditssyntheticderivative6cltgqalterinsulinsecretionevidencefordiminishingglucoseuptakeasamechanism AT caoyanyang naturalcompoundapgganditssyntheticderivative6cltgqalterinsulinsecretionevidencefordiminishingglucoseuptakeasamechanism AT wangxuan naturalcompoundapgganditssyntheticderivative6cltgqalterinsulinsecretionevidencefordiminishingglucoseuptakeasamechanism AT liyunsheng naturalcompoundapgganditssyntheticderivative6cltgqalterinsulinsecretionevidencefordiminishingglucoseuptakeasamechanism AT shriwaspratik naturalcompoundapgganditssyntheticderivative6cltgqalterinsulinsecretionevidencefordiminishingglucoseuptakeasamechanism AT qianyanrong naturalcompoundapgganditssyntheticderivative6cltgqalterinsulinsecretionevidencefordiminishingglucoseuptakeasamechanism AT archermichaelw naturalcompoundapgganditssyntheticderivative6cltgqalterinsulinsecretionevidencefordiminishingglucoseuptakeasamechanism AT whitticarnicholasb naturalcompoundapgganditssyntheticderivative6cltgqalterinsulinsecretionevidencefordiminishingglucoseuptakeasamechanism AT jahanishrat naturalcompoundapgganditssyntheticderivative6cltgqalterinsulinsecretionevidencefordiminishingglucoseuptakeasamechanism AT nunemakercraigs naturalcompoundapgganditssyntheticderivative6cltgqalterinsulinsecretionevidencefordiminishingglucoseuptakeasamechanism AT guoaili naturalcompoundapgganditssyntheticderivative6cltgqalterinsulinsecretionevidencefordiminishingglucoseuptakeasamechanism |